![The COVID challenge: Maintaining progress in multiple myeloma clinical investigation](https://cdn.cancerletter.com/media/2020/07/23161627/myeloma_4x3.jpg)
![The COVID challenge: Maintaining progress in multiple myeloma clinical investigation](https://cdn.cancerletter.com/media/2020/07/23161627/myeloma_4x3.jpg)
Cover Story
COVID-19 & CancerFreeGuest Editorial
The past two decades have brought hope to myeloma patients, as the majority benefit from the significant advances in chemotherapy.
Free
By Matthew Bin Han Ong
In Brief
Clinical Roundup
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
Drugs & Targets
![Drugs & Targets](https://cdn.cancerletter.com/media/2019/05/03161633/targets2.jpg)
![Drugs & Targets](https://cdn.cancerletter.com/media/2019/05/03161633/targets2.jpg)
Trending Stories
- “All in Her Head” catalogs the history of medicine’s atrocities against women
- CM24 combination improves clinical outcomes in advanced metastatic PDAC in phase II study interim data
- Prominent GI oncologist Axel Grothey was forced out of Mayo Clinic for unethical sexual relationships with women he mentored
Three reprimands later, he retains leadership—and mentorship—positions - Chernobyl: a 35 year follow up on long-term health effects
- The unKOOL, unfiltered history of menthol cigarettes
- CMS starts paying for patient navigation; ACS offers navigation credentialing program